Racial disparities in early-stage NSCLC treatment: A Call for Action.
Bruna PelliniAadel A ChaudhuriPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Non-small cell lung cancer (NSCLC) is associated with a 5-year survival rate of only 28%, however, when caught at an early stage, it can be cured with surgery or stereotactic body radiotherapy (SBRT). Unfortunately, racial disparities may result in limited access to care for some patients. Liu et al. analyzed 64,999 cases of early-stage NSCLC treated between 2005 and 2017 from the Florida cancer registry and showed that Black patients had 36% lower odds of receiving curative-intent surgery compared to their White counterparts. This study highlights significant racial disparities in treatment patterns that must be addressed urgently.
Keyphrases
- early stage
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- healthcare
- advanced non small cell lung cancer
- squamous cell carcinoma
- peritoneal dialysis
- sentinel lymph node
- affordable care act
- atrial fibrillation
- combination therapy
- quality improvement
- tyrosine kinase
- lymph node metastasis